Persephoni develops and operates a venture studio focusing on building biotech companies from breakthrough scientific research. The company identifies promising early-stage science and works closely with academic institutions, scientists, and investors to create structured pathways for turning discoveries into commercial ventures. It provides operational support, funding strategies, and company-building expertise to accelerate the formation and development of new biotech entities. Its model includes assembling founding teams, designing business models, and navigating early clinical and regulatory milestones. The studio prioritizes areas with potential for significant medical or scientific impact, supporting technologies across fields such as therapeutics, diagnostics, and synthetic biology. It acts as both incubator and founder, actively shaping the scientific, financial, and strategic direction of each company it launches.